Shares of Semler Scientific Inc. (NASDAQ:SMLR - Get Free Report) were up 8% on Thursday . The stock traded as high as $46.50 and last traded at $45.69. Approximately 400,454 shares were traded during trading, a decline of 29% from the average daily volume of 560,628 shares. The stock had previously closed at $42.32.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on SMLR shares. Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 price target on the stock in a research report on Wednesday. Benchmark initiated coverage on shares of Semler Scientific in a research report on Tuesday. They set a "buy" rating and a $101.00 price target on the stock. Finally, Wall Street Zen cut shares of Semler Scientific from a "buy" rating to a "sell" rating in a research report on Thursday, May 22nd.
Check Out Our Latest Stock Analysis on Semler Scientific
Semler Scientific Price Performance
The company has a market capitalization of $624.20 million, a PE ratio of -17.43 and a beta of 1.39. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. The company's 50 day simple moving average is $37.29 and its 200 day simple moving average is $42.24.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. Semler Scientific had a negative net margin of 60.69% and a positive return on equity of 19.75%. The firm had revenue of $8.84 million during the quarter.
Hedge Funds Weigh In On Semler Scientific
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Jones Financial Companies Lllp purchased a new stake in shares of Semler Scientific during the 4th quarter worth $34,000. Charles Schwab Investment Management Inc. increased its position in shares of Semler Scientific by 11.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 48,625 shares of the company's stock valued at $2,626,000 after buying an additional 4,802 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Semler Scientific in the fourth quarter valued at $1,939,000. Larson Financial Group LLC purchased a new stake in Semler Scientific during the 4th quarter worth about $38,000. Finally, Douglass Winthrop Advisors LLC purchased a new stake in Semler Scientific during the 4th quarter worth about $232,000. 49.37% of the stock is currently owned by hedge funds and other institutional investors.
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Stories
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.